BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 11801488)

  • 1. Sustained complete remission following a combination of very low intensity chemotherapy with rituximab in an elderly patient with Burkitt's lymphoma.
    Cohen Y; Amir G; Rachmilewitz EA; Polliack A
    Haematologica; 2002 Jan; 87(1):ELT04. PubMed ID: 11801488
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term survival of two patients with Burkitt's lymphoma treated by surgical resection and intensive chemotherapy].
    Matsuoka T; Yoshimoto S; Sonobe H; Kiyoku Y; Yamasaki M; Taguchi H; Miyoshi I
    Rinsho Ketsueki; 1988 Nov; 29(11):2101-4. PubMed ID: 3236417
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary Burkitt's lymphoma of the ovary.
    Cyriac S; Srinivas L; Mahajan V; Sundersingh S; Sagar TG
    Afr J Paediatr Surg; 2010; 7(2):120-1. PubMed ID: 20431226
    [No Abstract]   [Full Text] [Related]  

  • 4. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
    Kanaji N; Ishibashi K; Uno H; Hino N
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2569-72. PubMed ID: 12506485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.
    Thomas DA; Faderl S; O'Brien S; Bueso-Ramos C; Cortes J; Garcia-Manero G; Giles FJ; Verstovsek S; Wierda WG; Pierce SA; Shan J; Brandt M; Hagemeister FB; Keating MJ; Cabanillas F; Kantarjian H
    Cancer; 2006 Apr; 106(7):1569-80. PubMed ID: 16502413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-related lymphoma treated with maintenance thalidomide.
    Larson ML; Enschede SH; Gregory SA
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):231-4; discussion 234-5. PubMed ID: 16166993
    [No Abstract]   [Full Text] [Related]  

  • 7. [Early relapse of Burkitt's lymphoma with t(8;14) and t(14;18) after rituximab-combined CODOX-M and IVAC therapy].
    Fujishima N; Fujishima M; Inomata M; Yamanaka Y; Saitoh K; Kameoka Y; Yoshioka T; Saitoh H; Takahashi N; Hirokawa M; Sawada K
    Rinsho Ketsueki; 2007 Apr; 48(4):326-31. PubMed ID: 17515125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of HIV-associated Burkitt Lymphoma in the presence of severe hepatic dysfunction.
    Chen R; Abbott BL; Myint H
    Clin Adv Hematol Oncol; 2006 Nov; 4(11):841-4; discussion 844-7. PubMed ID: 17143254
    [No Abstract]   [Full Text] [Related]  

  • 9. Burkitt's lymphoma-- what is new?
    Abinya ON
    East Afr Med J; 2008 May; 85(5):205-6. PubMed ID: 18814529
    [No Abstract]   [Full Text] [Related]  

  • 10. Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
    Mandigers CM; Verdonck LF; Meijerink JP; Dekker AW; Schattenberg AV; Raemaekers JM
    Bone Marrow Transplant; 2003 Dec; 32(12):1159-63. PubMed ID: 14647270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab in a child with relapsed Burkitt lymphoma.
    Bay A; Dogan M; Acikgoz M; Oner AF
    Pediatr Blood Cancer; 2007 Aug; 49(2):218. PubMed ID: 16847929
    [No Abstract]   [Full Text] [Related]  

  • 12. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
    Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
    Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report and review of immunodeficiency-associated Burkitt lymphoma.
    Johnson DH; Reske T; Ruiz M
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):e121-5. PubMed ID: 25701328
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-term remission of a case of Burkitt's lymphoma accompanied by cardiac tamponade treated by surgical resection and intensive chemotherapy].
    Ikematsu W; Aso T; Hirota Y; Okamura H; Matsumoto I; Ayabe S; Matsuzaka T; Iwashita A
    Rinsho Ketsueki; 1990 Oct; 31(10):1731-5. PubMed ID: 2255064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of rituximab treatment during pregnancy on a neonate.
    Friedrichs B; Tiemann M; Salwender H; Verpoort K; Wenger MK; Schmitz N
    Haematologica; 2006 Oct; 91(10):1426-7. PubMed ID: 16963391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous bone-marrow transplantation for Burkitt's lymphoma: marrow purging with anti-Y 29/55 monoclonal antibody and complement.
    Baumgartner C; Delaleu B; Imbach P; Lüthy A; Odavic R; Brun del Re G; Bucher U; Forster HK; Hirt A; Wagner HP
    IARC Sci Publ; 1985; (60):435-40. PubMed ID: 3905594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pembrolizumab and lenalidomide induced remission in refractory double-hit lymphoma.
    Chan TS; Khong PL; Kwong YL
    Ann Hematol; 2016 Oct; 95(11):1917-8. PubMed ID: 27473194
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of rituximab in diffuse large B-cell lymphoma in the salvage setting.
    Gisselbrecht C
    Br J Haematol; 2008 Dec; 143(5):607-21. PubMed ID: 18950460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined treatment with anti-CD20 (rituximab) and CHOP in relapsed advanced-stage follicular lymphomas.
    Domingo-Domènech E; González-Barca E; Estany C; Sureda A; Besalduch J; Fernández de Sevilla A
    Haematologica; 2002 Nov; 87(11):1229-30. PubMed ID: 12414357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary non-Hodgkin lymphoma of the kidney.
    Büchi G; Ganio L; Negro C; Veglio M; Revigliono G; Termine G
    Pathologica; 1992; 84(1091):393-6. PubMed ID: 1465324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.